Nonpegylated liposomal doxorubicin as a component of R-CHOP is an effective and safe alternative to conventional doxorubicin in the treatment of patients with diffuse large B-Cell lymphoma and preexisting cardiac diseases

Saved in:
Bibliographic Details
Main Authors: Rohlfing, Sarah (Author) , Aurich, Matthias (Author) , Schöning, Tilman (Author) , Ho, Anthony Dick (Author) , Witzens-Harig, Mathias (Author)
Format: Article (Journal)
Language:English
Published: August 2015
In: Clinical lymphoma, myeloma & leukemia
Year: 2015, Volume: 15, Issue: 8, Pages: 458-463
ISSN:2152-2669
DOI:10.1016/j.clml.2015.03.008
Online Access:Verlag, Volltext: http://dx.doi.org/10.1016/j.clml.2015.03.008
Get full text
Author Notes:Sarah Rohlfing, Matthias Aurich, Tilman Schöning, Anthony D. Ho, Mathias Witzens-Harig
Description
Item Description:Gesehen am 19.01.2017
Physical Description:Online Resource
ISSN:2152-2669
DOI:10.1016/j.clml.2015.03.008